Genpharmasec Statistics

Total Valuation

Genpharmasec has a market cap or net worth of INR 1.13 billion. The enterprise value is 1.13 billion.

Market Cap	1.13B
Enterprise Value	1.13B

Important Dates

The last earnings date was Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Genpharmasec has 533.72 million shares outstanding.

Current Share Class	533.72M
Shares Outstanding	533.72M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	49.73%
Owned by Institutions (%)	5.30%
Float	252.59M

Valuation Ratios

The trailing PE ratio is 91.90.

PE Ratio	91.90
Forward PE	n/a
PS Ratio	3.36
PB Ratio	1.73
P/TBV Ratio	1.74
P/FCF Ratio	n/a
P/OCF Ratio	37.77
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	92.01
EV / Sales	3.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-41.80

Financial Position

The company has a current ratio of 2.86, with a Debt / Equity ratio of 0.08.

Current Ratio	2.86
Quick Ratio	1.92
Debt / Equity	0.08
Debt / EBITDA	82.19
Debt / FCF	-1.95
Interest Coverage	-1.72

Financial Efficiency

Return on equity (ROE) is 1.90% and return on invested capital (ROIC) is -0.67%.

Return on Equity (ROE)	1.90%
Return on Assets (ROA)	-0.62%
Return on Invested Capital (ROIC)	-0.67%
Return on Capital Employed (ROCE)	-1.07%
Revenue Per Employee	33.72M
Profits Per Employee	1.23M
Employee Count	10
Asset Turnover	0.45
Inventory Turnover	3.75

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.03% in the last 52 weeks. The beta is -0.79, so Genpharmasec's price volatility has been lower than the market average.

Beta (5Y)	-0.79
52-Week Price Change	+6.03%
50-Day Moving Average	2.08
200-Day Moving Average	2.69
Relative Strength Index (RSI)	47.57
Average Volume (20 Days)	405,469

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genpharmasec had revenue of INR 337.22 million and earned 12.31 million in profits.

Revenue	337.22M
Gross Profit	41.74M
Operating Income	-7.47M
Pretax Income	18.80M
Net Income	12.31M
EBITDA	643,000
EBIT	-7.47M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 52.71 million in cash and 52.85 million in debt, giving a net cash position of -131,000 or -0.00 per share.

Cash & Cash Equivalents	52.71M
Total Debt	52.85M
Net Cash	-131,000
Net Cash Per Share	-0.00
Equity (Book Value)	652.80M
Book Value Per Share	n/a
Working Capital	183.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 29.96 million and capital expenditures -57.05 million, giving a free cash flow of -27.10 million.

Operating Cash Flow	29.96M
Capital Expenditures	-57.05M
Free Cash Flow	-27.10M
FCF Per Share	-0.05

Full Cash Flow Statement

Margins

Gross margin is 12.38%, with operating and profit margins of -2.22% and 3.65%.

Gross Margin	12.38%
Operating Margin	-2.22%
Pretax Margin	5.58%
Profit Margin	3.65%
EBITDA Margin	0.19%
EBIT Margin	-2.22%
FCF Margin	n/a

Dividends & Yields

Genpharmasec does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.09%
FCF Yield	-2.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 11, 2019. It was a forward split with a ratio of 10.

Last Split Date	Apr 11, 2019
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a